Efficacy of nab-paclitaxel on 5-fluorouracil (5-FU) resistant human gastric cancer cell lines

被引：0
|
作者：
Nukatsuka, Mamoru [1 ]
Kobunai, Takashi [2 ]
Matsuoka, Kazuaki [1 ]
Takechi, Teiji [2 ]
机构：
[1] Taisho Pharmaceut Co Ltd, Tokushima, Japan
[2] Taisho Pharmaceut Co Ltd, Tokyo, Japan
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-777
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
777
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF NAB-PACLITAXELON 5-FLUOROURACIL (5FU) RESISTANT HUMAN GASTRIC CANCER CELL LINES
    Nukatsuka, Mamoru
    Kobunai, Takashi
    Matsuoka, Kazuaki
    Takechi, Teiji
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [2] Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
    De Angelis, Paula M.
    Svendsrud, Debbie H.
    Kravik, Katherine L.
    Stokke, Trond
    [J]. MOLECULAR CANCER, 2006, 5 (1)
  • [3] Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
    Paula M De Angelis
    Debbie H Svendsrud
    Katherine L Kravik
    Trond Stokke
    [J]. Molecular Cancer, 5
  • [4] METABOLISM OF 5-FLUOROURACIL (5-FU) IN HUMAN GASTROINTESTINAL CANCER
    BERNE, M
    ALMERSJO, O
    GUSTAVSSON, B
    [J]. ACTA CHIRURGICA SCANDINAVICA, 1983, : 31 - 31
  • [5] Synergistic activity of the Akt inhibitor perifosine and 5-fluorouracil in 5-FU resistant gastric cancer
    Song, Kim Hyo
    Shin, You Keun
    Zhang, Xianglan
    Kim, Jung Min Kim
    Kim, Tae Soo
    Park, Chan Hee
    Jang, Woo Ick
    Engel, Juergen
    Rha, Sun Young Rha
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [6] 5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene
    M. Osaki
    S. Tatebe
    A. Goto
    H. Hayashi
    M. Oshimura
    H. Ito
    [J]. Apoptosis, 1997, 2 : 221 - 226
  • [7] 5-fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene
    Osaki, M
    Tatebe, S
    Goto, A
    Hayashi, H
    Oshimura, M
    Ito, H
    [J]. APOPTOSIS, 1997, 2 (02) : 221 - 226
  • [8] NAB-paclitaxel as third-line therapy after failure of gemcitabine and 5-fluorouracil (5-FU) based combinations in advanced gall bladder cancer patients
    Goel, V.
    Talwar, V.
    Patnaik, N.
    Raina, S.
    Singh, S.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [9] 5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-Response
    Sharma, Manish R.
    Joshi, Smita S.
    Kindler, Hedy L.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3890 - 3890
  • [10] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
12345